Towards better diagnosis of neurodegenerative disorders: Skin biopsy for α-synuclein detection proves effective

The FDA on Mon­day re­leased new draft guid­ance on con­duct­ing mul­ti-re­gion­al on­col­o­gy tri­als, say­ing its “para­mount con­sid­er­a­tion” is whether the re­sults ap­ply to the in­tend­ed

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

The FDA approved zuranolone (Zurzuvae) as the first oral treatment for postpartum depression, the agency announced late on Friday. Until now, brexanolone (Zulresso) has been